Literature DB >> 16818858

Rapidly increasing incidence of ocular non-hodgkin lymphoma.

Roxana Moslehi1, Susan S Devesa, Catherine Schairer, Joseph F Fraumeni.   

Abstract

A recent report suggesting that ocular adnexal non-Hodgkin lymphoma (NHL) may be related to Chlamydia psittaci infection underscores the need for reliable epidemiologic data for this malignancy. We examined population-based incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program. During 1992-2001 in the 12 SEER areas, ocular (i.e., eye and adnexa) NHL rates per 100,000 person-years for both sexes were highest among Asians/Pacific Islanders, lower in whites, and lower still in blacks. Incidence increased with advancing age and showed little difference by sex, in contrast to other (extranodal and nodal) NHLs, which occurred predominantly in males. From 1975-2001, there was a rapid and steady increase in incidence of ocular NHL, with annual increases of 6.2% and 6.5% among white males and females, respectively, with no evidence of peaking. By contrast, other NHLs showed evidence of peaking in recent years. The distinctive patterns of ocular NHL call for further studies to identify risk factors and mechanisms, including the potential role of C. psittaci or other infections.

Entities:  

Mesh:

Year:  2006        PMID: 16818858     DOI: 10.1093/jnci/djj248

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  37 in total

1.  Translocation (5; 11) in a conjunctival MALT lymphoma.

Authors:  Cecilia G Clement; Venkateswara R Potluri; John Gonzales; You-Wen Qian
Journal:  Int J Clin Exp Pathol       Date:  2011-09-30

2.  Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience.

Authors:  M Smiljanic; R Milosevic; D Antic; B Andjelic; V Djurasinovic; M Todorovic; J Bila; A Bogdanovic; B Mihaljevic
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

Review 3.  [Chlamydial diseases of the eye. A short overview].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

4.  Histopathological Features and Ann Arbor Stage in Periocular Lymphoma.

Authors:  Marco Zschoche; Annette Zimpfer; Björn O Scheef; Anselm M Jünemann; Rudolf F Guthoff; Christian Junghanss; Guido Hildebrandt; Steffen Emmert; Andreas Erbersdobler; Günther Kundt; Vinodh Kakkassery
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

5.  Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin's lymphoma.

Authors:  Roxana Moslehi; F Bruce Coles; Maria J Schymura
Journal:  Expert Rev Ophthalmol       Date:  2011

6.  Incidence of orbital, conjunctival and lacrimal gland malignant tumors in USA from Surveillance, Epidemiology and End Results, 1973-2009.

Authors:  Waleed M Hassan; Mohamed S Bakry; Housam M Hassan; Ahmad S Alfaar
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

7.  A cluster of vitreoretinal lymphoma in New York with possible link to the Chernobyl nuclear disaster.

Authors:  Sanford Kempin; Paul T Finger; Robert Peter Gale; John Rescigno; Jeffrey Rubin; Walter Choi; Rebecca Fisher; Alexander Aizman; Ilona Genis; Stephen C Malamud; Roxana Moslehi
Journal:  Leuk Lymphoma       Date:  2017-11-22

8.  Clinical features and treatment outcomes of primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: a single center retrospective analysis of 64 patients in China.

Authors:  Hui Yu; Yu-Xin Du; Zhen-Chang Sun; Xiao-Rui Fu; Nan Tan; Wei-Feng Gong; Ming-Zhi Zhang
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

Review 9.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

Review 10.  Extranodal marginal zone lymphoma of the ocular adnexa.

Authors:  Alexandra Stefanovic; Izidore S Lossos
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.